Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Global Times: Spring Festival hustle and bustle back, heralds vibrant year ahead
2023-01-20 13:26
BriSTAR Immunotech To Present its Novel Cell Therapy for Acute Myeloid Leukemia at the AACR Special Conference on AML and MDS
2023-01-20 13:10
$412.5 million! Mabwell Announces Exclusive Licensing Agreement with DISC MEDICINE, INC. for Innovative Drug Candidates of Hematologic Diseases
2023-01-20 09:50
NEW THERAPY TO TREAT RARE GASTROINTESTINAL STROMAL TUMOUR APPROVED FOR NEW ZEALAND PATIENTS
2023-01-20 02:00
Hepagene Therapeutics Reports Positive Top-line Results for Phase 2a RISE Study of FXR Agonist HPG1860 in Patients with NASH
2023-01-19 23:00
Health In Tech Partners with 6 Degree Health and 90 Degree Benefits to Form a New Value-Based, Level-Funded Health Plan
2023-01-19 21:30
Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer Treatment
2023-01-19 20:30
Tigermed Completes Acquisition of Marti Farm
2023-01-19 14:59
China's First and Only Approved Third-Generation BCR-ABL Inhibitor Olverembatinib Included into the 2022 National Reimbursement Drug List
2023-01-19 11:45
Everise Repositions Branding to Cement Evolution as End-to-End Customer Service Player
2023-01-18 22:00
Lunit Highlights the Effectiveness of AI in Predicting Cancer Treatment Outcomes - Findings to be Presented at ASCO GI 2023
2023-01-18 21:00
Keymed Biosciences | The Latest Results from the Phase Ia Clinical Study of CMG901 was presented at the 2023 ASCO GI CANCERS SYMPOSIUM
2023-01-18 09:52
IASO Bio Raises Nearly $75 Million in Series C1 Funding
2023-01-18 08:00
Asieris Appoints Dr. Linda Wu as Chief Development Officer
2023-01-18 07:00
Tanso Biosciences Expands Its Line-up with 250 Mouse GPCRs
2023-01-18 00:00
Hybribio returns to Medlab Middle East 2023
2023-01-17 22:30
Health supplement information app Pillwork set for launch in the first-half year
2023-01-17 15:03
Organon Is Recognized as Both "Top Employers China 2023" And "Best Workplaces™ in Greater China 2022"
2023-01-17 13:06
Full-Life Technologies Announces Appointment of Steffen Heeger, MD, PhD, as Chief Medical Officer and Fa Liu, PhD, as Chief Scientific Officer
2023-01-17 10:00
FDA Accepts GMP Plasmid DMF of OBiO Technology
2023-01-17 08:00
1
107
108
109
110
111
801